US2022192123A1PendingUtilityA1

Industrial hemp cannabis cultivars and seeds with stable cannabinoid profiles

Assignee: NEW WEST GENETICS INCPriority: May 27, 2016Filed: Mar 15, 2022Published: Jun 23, 2022
Est. expiryMay 27, 2036(~9.8 yrs left)· nominal 20-yr term from priority
A01H 5/12A01H 6/28C12C 7/28
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

According to the invention, there is provided novel hemp Cannabis cultivars with THC content of 0.2% by dry weight and a unique terpene profile. This invention thus relates to the seeds of hemp Cannabis cultivars of the invention, to the plants of hemp Cannabis cultivars of the invention, to plant parts of hemp Cannabis cultivars of the invention, to methods for producing a Cannabis cultivar by crossing the hemp Cannabis cultivars of the invention with another Cannabis cultivar, and to methods for producing a Cannabis cultivar containing in its genetic material one or more backcross conversion traits or transgenes and to the backcross conversion Cannabis plants and plant parts produced by those methods.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A non-transgenic elite  Cannabis  cultivar with a THC content of 0.2% or less which can be reproduced through seed propagation and which can be grown in diverse environmental conditions with a stable Cannabinoid profile. 
     
     
         2 . The  Cannabis  cultivar of  claim 1  wherein said cultivar is not produced through asexual propagation. 
     
     
         3 . Seed of  Cannabis  cultivar of  claim 1  which reliably and stably produces a THC content of 0.2% or less and elite germplasm traits. 
     
     
         4 . A  Cannabis  plant, or a part thereof, produced by growing the seed of  claim 3 . 
     
     
         5 . A tissue culture of cells produced from the plant of  claim 4 , wherein said cells of the tissue culture are produced from a plant part selected from the group consisting of embryo, meristematic cell, leaf, cotyledon, hypocotyl, stem, root, root tip, pistil, anther, flower, seed and pollen. 
     
     
         6 . A protoplast produced from the plant of  claim 4 . 
     
     
         7 . A protoplast produced from the tissue culture of  claim 5 . 
     
     
         8 . A  Cannabis  plant regenerated from the tissue culture of  claim 5 . 
     
     
         9 . A method for producing a hybrid  Cannabis  seed, wherein the method comprises crossing the plant of  claim 1  with a different  Cannabis  plant and harvesting the resultant F 1  hybrid  Cannabis  seed. 
     
     
         10 . A hybrid  Cannabis  seed produced by the method of  claim 9 . 
     
     
         11 . A hybrid  Cannabis  plant, or a part thereof, produced by growing said hybrid seed of  claim 10 . 
     
     
         12 . A method of producing a male sterile  Cannabis  plant wherein the method comprises transforming the  Cannabis  plant of  claim 1  with a nucleic acid molecule that confers male sterility. 
     
     
         13 . A male sterile  Cannabis  plant produced by the method of  claim 12 . 
     
     
         14 . A method for producing an herbicide resistant  Cannabis  plant wherein the method comprises transforming the  Cannabis  plant of  claim 1  with a transgene, wherein the transgene confers resistance to an herbicide selected from the group consisting of imidazolinone, sulfonylurea, glyphosate, glufosinate, L-phosphinothricin, triazine and benzonitrile. 
     
     
         15 . An herbicide resistant  Cannabis  plant produced by the method of  claim 14 . 
     
     
         16 . A method of producing an insect resistant  Cannabis  plant wherein the method comprises transforming the  Cannabis  plant of  claim 1  with a transgene that confers insect resistance. 
     
     
         17 . An insect resistant  Cannabis  plant produced by the method of  claim 16 . 
     
     
         18 . The  Cannabis  plant of  claim 17  wherein the transgene encodes a  Bacillus thuringiensis  endotoxin. 
     
     
         19 . A method of producing a disease resistant  Cannabis  plant wherein the method comprises transforming the  Cannabis  plant of  claim 1  with a transgene that confers disease resistance. 
     
     
         20 . A disease resistant  Cannabis  plant produced by the method of  claim 19 . 
     
     
         21 . A method of producing a  Cannabis  plant with a value-added trait, wherein the method comprises transforming the  Cannabis  plant of  claim 1  with a heterologous nucleic acid sequence. 
     
     
         22 . A  Cannabis  plant with a value-added trait produced by the method of  claim 21 . 
     
     
         23 . A method of producing a  Cannabis  plant with a THC content of 0.2% or less comprising the steps of:
 (a) crossing the plant of  claim 1  with a second  Cannabis  plant to produce a progeny plant;   (b) crossing the progeny plant of step (a) with itself or the second  Cannabis  plant in step (a) to produce a seed;   (c) growing a progeny plant of a subsequent generation from the seed produced in step (b);   (d) crossing the progeny plant of a subsequent generation of step (c) with itself or the second  Cannabis  plant in step (a) to produce a  Cannabis  plant with a THC content of 0.2% or less.   
     
     
         24 . A method for developing a  Cannabis  plant in a  Cannabis  plant breeding program, comprising applying plant breeding techniques comprising recurrent selection, backcrossing, pedigree breeding, marker enhanced selection, mutation breeding, or genetic modification to the  Cannabis  plant of  claim 1 , or its parts, to develop of a  Cannabis  plant with a THC content of 0.2% or less.

Join the waitlist — get patent alerts

Track US2022192123A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.